| Mrs Hilary Cynthia Kuper Usiatynski, MS CCC-SLP | |
|
170 Intrepid Lane, High Peaks Rehab., Syracuse, NY 13205 | |
| (315) 492-8319 | |
| (315) 492-3758 |
| Full Name | Mrs Hilary Cynthia Kuper Usiatynski |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 170 Intrepid Lane, Syracuse, New York |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053566901 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 91741 (New York) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Hilary Cynthia Kuper Usiatynski, MS CCC-SLP 170 Intrepid Lane, High Peaks Rehab., Syracuse, NY 13205 Ph: (315) 492-8319 | Mrs Hilary Cynthia Kuper Usiatynski, MS CCC-SLP 170 Intrepid Lane, High Peaks Rehab., Syracuse, NY 13205 Ph: (315) 492-8319 |
News Archive
A personalized cancer vaccine markedly improved outcomes for patients suffering from acute myeloid leukemia (AML), a potentially lethal blood cancer, in a clinical trial led by investigators at Beth Israel Deaconess Medical Center.
POZEN Inc., a pharmaceutical company committed to transforming medicines that transform lives, today announced that the United States District Court for the Eastern District of Texas has issued a favorable verdict in the litigation between POZEN and several generic pharmaceutical companies which had filed Abbreviated New Drug Applications (ANDAs) seeking approval from the U.S. Food and Drug Administration (FDA) to market generic copies of Treximet.
Omeros Corporation today, in response to investor questions, announced that it plans to file a patent infringement lawsuit against Par Pharmaceutical, Inc. and its subsidiary, Par Sterile Products, LLC in response to the Abbreviated New Drug Application (ANDA) filed by Par seeking FDA approval to market a generic version of Omeros' commercial drug Omidria (phenylephrine and ketorolac injection) 1%/0.3%.
A clinical trial of 75 patients hospitalized with acute decompensated heart failure suggests that aggressive fluid and sodium restriction has no effect on weight loss or clinical stability at three days but was associated with an increase in perceived thirst, according to a study published Online First by JAMA Internal Medicine, a JAMA Network publication.
The Infectious Disease Research Institute today announced it has received a multi-million dollar grant from the Defense Advanced Research Projects Agency, and the Army Research Office, both parts of United States Department of Defense.
› Verified 2 days ago
Mrs. Janet M Gibbons, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 171 Intrepid Ln, Syracuse, NY 13205 Phone: 315-437-4689 Fax: 315-437-4698 | |
Anya Freedman-doan, Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 3175 E Genesee St Ste 5, Syracuse, NY 13224 Phone: 315-810-2423 | |
Ms. Jacqueline Ann Caughey, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 725 Harrison St, Syracuse, NY 13210 Phone: 315-435-4204 | |
Ms. Sujini Ramachandar, M.S.CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1744 W Genesee St, Syracuse, NY 13204 Phone: 315-468-3414 Fax: 315-468-2089 | |
Ms. Sharon Schneider Pollock, M.S. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 800 Irving Ave, Audiology And Speech Pathology (126), Syracuse, NY 13210 Phone: 315-425-4400 Fax: 315-425-2440 | |
Mrs. Beatriz Rholyn Nalli, M.S., CCC-SLP/L Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 171 Intrepid Ln, Syracuse, NY 13205 Phone: 315-437-4689 | |
Maureen Ann Robinson, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1951 Caleb Ave, Syracuse, NY 13206 Phone: 315-218-7444 Fax: 315-218-7466 |